News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Concept Life Sciences has acquired Aquila BioMedical, citing the CRO’s specific skill set, which will allow the company to provide services in areas “not previously accessible,” says executive chairman.
Curevac AG has started building a RNA therapeutics plant in Tubingen, Germany.
BIOPRODUCTION CONGRESS DUBLIN 2017
Firms should identify risks prior to inspection, make staff available during regulator visits, and respond promptly post-inspection when undergoing GMP site checks, says Ireland’s Health Products Regulatory Authority (HPRA).